Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethosuximide in peripheral neuropathic pain
NCT04431778Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Nov 2020
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ethosuximide in Peripheral neuropathic pain, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
ethosuximide
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT04431778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04431778.